Related Experiment Videos
[Cis- and trans- mutations in genetic diseases].
1Clinique de Recherches de Génétique Médicale, INSERM U-12, Hôpital des Enfants-Malades, Paris, France.
Pathologie-Biologie
|April 1, 1988
Summary
Genetic defects in gene regulatory elements are poorly understood. This study proposes using metabolic diseases to uncover new factors in trans-regulation of gene expression.
Area of Science:
- Genetics
- Molecular Biology
- Systems Biology
Context:
- While gene coding region mutations are well-documented, genetic defects in regulatory elements (cis-acting) and gene expression regulators (trans-acting) remain largely unknown.
- Few studies have investigated the downstream effects of single gene defects on the expression of other genes and overall in vivo functions.
Purpose:
- To explore the potential of using naturally occurring diseases, specifically metabolic disorders, as models to understand gene expression regulation.
- To identify novel trans-acting factors involved in the coordinate regulation of gene expression through pathophysiological pathways.
Summary:
- This research proposes leveraging human diseases, particularly inborn and acquired metabolic diseases, as natural experiments.
- The study aims to investigate how these diseases can illuminate the poorly understood mechanisms of trans-regulation of gene expression.
- By examining disease models, the research seeks to identify unknown factors that influence the coordinated expression of multiple genes.
Impact:
- This work could significantly advance our understanding of gene expression control beyond coding regions.
- Identifying novel trans-acting factors may reveal new therapeutic targets for genetic disorders.
- The findings may provide a new framework for studying gene regulation through the lens of disease pathophysiology.